跳至主要内容
临床试验/IRCT20200429047235N2
IRCT20200429047235N2招募中3 期

The effect of astaxanthin supplementation on antioxidant status, inflammation status, disease severity and physical performance in patients with rheumatoid arthritis

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age between 18 and 65 years
  • Rheumatoid arthritis diagnosis by a specialist physician based on criteria (ACR)
  • Having a disease activity score (DAS) higher than 3.2
  • Willingness to participate in the study and complete the consent form before starting the supplement therapy
  • Not taking herbal and medicinal supplements, especially antioxidant supplements, in the three months before the start of the study
  • Having a body mass index of 18.5 to 40

排除标准

  • Pregnancy and breastfeeding
  • Smoking and being exposed to cigarette smoke on a daily basis
  • Consumption of alcoholic beverages
  • Following a special diet or exercise program
  • Suffering from diseases such as diabetes mellitus, high blood pressure, thyroid disorder, kidney failure, liver dysfunction, Cushing's syndrome
  • Inflammatory bowel diseases (Crohn's and ulcerative colitis)
  • Using traditional medicine methods in the last 3 months
  • Infectious rheumatoid arthritis
  • Having a history of bariatric surgery
  • Consumption of less than 80% of the total astaxanthin food supplement

研究者

相似试验